Patents by Inventor Tim Costello

Tim Costello has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Digital search and collaboration process for recommendations, advertising, and buying decisions
    Patent number: 12321996
    Abstract: Disclosed are systems, methods, and media having at least one processor; and a non-transitory computer-readable medium storing instruction which, when executed by the at least one processor, cause the at least one processor to perform operations comprising receiving from one or more sources images related to a plurality of features of housing offerings, said images being associated with other images related to features of housing offerings; presenting to a first user an initial prompt and based on response to that initial prompt, presenting a plurality of selectable images related to a first feature of housing offerings; receiving from the first user input regarding the desirability of the images related to the first feature of housing offerings; and iteratively deriving, based on inputs regarding the desirability of the images related to one or more of the plurality of features of housing offerings, a hypothesis regarding a different feature of housing offerings; based at least in part on the hypothesis, pre
    Type: Grant
    Filed: April 10, 2023
    Date of Patent: June 3, 2025
    Assignee: Builders Digital Experience, LLC
    Inventors: Tim Costello, Mark Law, Krishna Murthy, Peter Brumme, Drew Leakey
  • Opioid receptor modulator dosage formulations
    Patent number: 12097187
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6 -dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy -benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Grant
    Filed: May 26, 2023
    Date of Patent: September 24, 2024
    Assignee: Allergan Holdings Unlimited Company
    Inventors: Tim Costello, Leonard Scott Dove, J. Michael Davenport, Gail McIntyre, Paul Covington, David Andrae
  • OPIOID RECEPTOR MODULATOR DOSAGE FORMULATIONS
    Publication number: 20230293493
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6 -dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy -benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Application
    Filed: May 26, 2023
    Publication date: September 21, 2023
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns
  • DIGITAL SEARCH AND COLLABORATION PROCESS FOR RECOMMENDATIONS, ADVERTISING, AND BUYING DECISIONS
    Publication number: 20230245253
    Abstract: Disclosed are systems, methods, and media having at least one processor; and a non-transitory computer-readable medium storing instruction which, when executed by the at least one processor, cause the at least one processor to perform operations comprising receiving from one or more sources images related to a plurality of features of housing offerings, said images being associated with other images related to features of housing offerings; presenting to a first user an initial prompt and based on response to that initial prompt, presenting a plurality of selectable images related to a first feature of housing offerings; receiving from the first user input regarding the desirability of the images related to the first feature of housing offerings; and iteratively deriving, based on inputs regarding the desirability of the images related to one or more of the plurality of features of housing offerings, a hypothesis regarding a different feature of housing offerings; based at least in part on the hypothesis, pre
    Type: Application
    Filed: April 10, 2023
    Publication date: August 3, 2023
    Inventors: Tim Costello, Mark Law, Krishna Murthy, Peter Brumme, Drew Leakey
  • Digital search and collaboration process for recommendations, advertising, and buying decisions
    Patent number: 11625795
    Abstract: Disclosed are systems, methods, and media having at least one processor; and a non-transitory computer-readable medium storing instruction which, when executed by the at least one processor, cause the at least one processor to perform operations comprising receiving from one or more sources images related to a plurality of features of housing offerings, said images being associated with other images related to features of housing offerings; presenting to a first user an initial prompt and based on response to that initial prompt, presenting a plurality of selectable images related to a first feature of housing offerings; receiving from the first user input regarding the desirability of the images related to the first feature of housing offerings; and iteratively deriving, based on inputs regarding the desirability of the images related to one or more of the plurality of features of housing offerings, a hypothesis regarding a different feature of housing offerings; based at least in part on the hypothesis, pre
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: April 11, 2023
    Assignee: Builders Digital Experience, LLC
    Inventors: Tim Costello, Mark Law, Krishna Murthy, Peter Brumme, Drew Leakey
  • Opioid receptor modulator dosage formulations
    Patent number: 11484527
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Grant
    Filed: December 8, 2021
    Date of Patent: November 1, 2022
    Assignee: Allergan Holdings Unlimited Company
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns
  • Opioid receptor modulator dosage formulations
    Patent number: 11311516
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Grant
    Filed: September 22, 2021
    Date of Patent: April 26, 2022
    Assignee: Allergan Holdings Unlimited Company
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns
  • OPIOID RECEPTOR MODULATOR DOSAGE FORMULATIONS
    Publication number: 20220096440
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Application
    Filed: December 8, 2021
    Publication date: March 31, 2022
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns
  • OPIOID RECEPTOR MODULATOR DOSAGE FORMULATIONS
    Publication number: 20220040151
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Application
    Filed: October 21, 2021
    Publication date: February 10, 2022
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns
  • Opioid receptor modulator dosage formulations
    Patent number: 11229627
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Grant
    Filed: October 21, 2021
    Date of Patent: January 25, 2022
    Assignee: Allergan Holdings Unlimited Company
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns
  • OPIOID RECEPTOR MODULATOR DOSAGE FORMULATIONS
    Publication number: 20220016034
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-4,5-dihydro-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Application
    Filed: July 17, 2020
    Publication date: January 20, 2022
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns
  • OPIOID RECEPTOR MODULATOR DOSAGE FORMULATIONS
    Publication number: 20220008394
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Application
    Filed: September 22, 2021
    Publication date: January 13, 2022
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Ema H. Heyns
  • Opioid receptor modulator dosage formulations
    Patent number: 11160792
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: November 2, 2021
    Assignee: Allergan Holdings Unlimited Company
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns
  • Opioid receptor modulator dosage formulations
    Patent number: 11090291
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Grant
    Filed: February 12, 2021
    Date of Patent: August 17, 2021
    Assignee: Allergan Holdings Unlimited Company
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns
  • OPIOID RECEPTOR MODULATOR DOSAGE FORMULATIONS
    Publication number: 20210205269
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Application
    Filed: March 24, 2021
    Publication date: July 8, 2021
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Ema H. Heyns
  • OPIOID RECEPTOR MODULATOR DOSAGE FORMULATIONS
    Publication number: 20210205268
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino }-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Application
    Filed: February 12, 2021
    Publication date: July 8, 2021
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns
  • Opioid receptor modulator dosage formulations
    Patent number: 11007179
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-4,5-dihydro-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Grant
    Filed: October 8, 2020
    Date of Patent: May 18, 2021
    Assignee: Allergan Holdings Unlimited Company
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns
  • OPIOID RECEPTOR MODULATOR DOSAGE FORMULATIONS
    Publication number: 20210030720
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-4,5-dihydro-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Application
    Filed: October 8, 2020
    Publication date: February 4, 2021
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns
  • DIGITAL SEARCH AND COLLABORATION PROCESS FOR RECOMMENDATIONS, ADVERTISING, AND BUYING DECISIONS
    Publication number: 20190378226
    Abstract: Disclosed are systems, methods, and media having at least one processor; and a non-transitory computer-readable medium storing instruction which, when executed by the at least one processor, cause the at least one processor to perform operations comprising receiving from one or more sources images related to a plurality of features of housing offerings, said images being associated with other images related to features of housing offerings; presenting to a first user an initial prompt and based on response to that initial prompt, presenting a plurality of selectable images related to a first feature of housing offerings; receiving from the first user input regarding the desirability of the images related to the first feature of housing offerings; and iteratively deriving, based on inputs regarding the desirability of the images related to one or more of the plurality of features of housing offerings, a hypothesis regarding a different feature of housing offerings; based at least in part on the hypothesis, pre
    Type: Application
    Filed: June 10, 2019
    Publication date: December 12, 2019
    Inventors: Tim Costello, Mark Law, Krishna Murthy, Peter Brumme, Drew Leakey
  • Opioid receptor modulator dosage formulations
    Patent number: 10188632
    Abstract: Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations.
    Type: Grant
    Filed: May 5, 2017
    Date of Patent: January 29, 2019
    Assignee: Allergan Holdings Unlimited Company
    Inventors: Tim Costello, Jens Jozef Ceulemans, Eugeen Maria Jozef Jans, Philip Erna H. Heyns